Research Study

A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents With Severe Uncontrolled Asthma (NAVIGATOR)
Principal Investigator 
Mark FitzGerald

Overview

Body Locations and Systems 
Asthma
ClinicalTrials.gov# 
NCT03347279
Status 
Recruiting
Study Start/End 
Feb 5, 2018 to Sep 18, 2020
Locations 
Diamond Health Care Centre
Name/Title 
Linda Hui, Research Coordinator
Phone 
604-875-5698
Email Address 
linda.hui@ubc.ca
Purpose of Study 

The purpose of the study is to see if Tezepelumab is effective in treating sever asthma and whether is causes any side effects.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.